Clinical Trial Update: Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of Helicobacter pylori eradication, Anti-D immunoglobulin, and danazol for steroid-dependent or refractory immune thrombo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Danazol (danazol)
• anti-D immunoglobulin (Rh(D) immune globulin)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Thrombocytopenia | Phase 2 | Status: UNKNOWN